Export

ATC codes: J01GB06
EMLc
Indication
Multi-drug resistant tuberculous Mycobacterium ICD11 code: ML32.00
INN
Amikacin
Medicine type
Chemical agent
Antibiotic groups
List type
Complementary Medicines for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.
Formulations
Parenteral > General injections > unspecified: 1 g in vial powder for injection (as sulfate) ; 500 mg in vial powder for injection (as sulfate) ; 100 mg in vial powder for injection (as sulfate)
EML status history
First added in 1999 (TRS 895)
Changed in 2007 (TRS 950)
Changed in 2009 (TRS 958)
Sex
All
Age
Also recommended for children
Therapeutic equivalence
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
Additional strengths of amikacin powder for injection were added to the complementary list of the EML and EMLc for treatment of MDR-TB.